InnoCare Pharma Limited logo

InnoCare Pharma Limited

HKEX:9969.HK

Overview | Financials
Company Name InnoCare Pharma Limited
Symbol 9969.HK
Currency HKD
Price 5.74
Market Cap 8,598,118,200
Dividend Yield 0%
52-week-range 4.03 - 7.49
Industry Biotechnology
Sector Healthcare
CEO Dr. Jisong Cui Ph.D.
Website https://www.innocarepharma.com

An error occurred while fetching data.

About InnoCare Pharma Limited

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r

Related Stocks

Grand Pharmaceutical Group Limited logo

Grand Pharmaceutical Group Limited

0512.HK

4.31 HKD

Shanghai Haohai Biological Technology Co., Ltd. logo

Shanghai Haohai Biological Technology Co., Ltd.

6826.HK

40.05 HKD

3SBio Inc. logo

3SBio Inc.

1530.HK

5.71 HKD

RemeGen Co., Ltd. logo

RemeGen Co., Ltd.

9995.HK

11.54 HKD

Jinxin Fertility Group Limited logo

Jinxin Fertility Group Limited

1951.HK

2.17 HKD

HUTCHMED (China) Limited logo

HUTCHMED (China) Limited

0013.HK

26.2 HKD

Jiangsu Recbio Technology Co., Ltd. logo

Jiangsu Recbio Technology Co., Ltd.

2179.HK

8.9 HKD

Shandong Xinhua Pharmaceutical Company Limited logo

Shandong Xinhua Pharmaceutical Company Limited

0719.HK

5.39 HKD

Sihuan Pharmaceutical Holdings Group Ltd. logo

Sihuan Pharmaceutical Holdings Group Ltd.

0460.HK

0.52 HKD

China Traditional Chinese Medicine Holdings Co. Limited logo

China Traditional Chinese Medicine Holdings Co. Limited

0570.HK

4.36 HKD

Financials

Numbers are in millions USD

Numbers are in millions USD